Emyria Ltd has safely dosed its first participant of its ethics-approved MDMA-assisted therapy (MDMA-AT) trial, EMDMA-001. This is a significant milestone.
Emyria Ltd (ASX:EMD) and the Pax Centre are aiming to make history as the first, integrated service in Australia to offer psychedelic-assisted therapy in a.
Emyria Ltd (ASX:EMD) has finalised the terms for the strategic acquisition of the Pax Centre, Australia’s leading multidisciplinary psychological trauma.
Companies sense opportunity in psychedelic legalisation bluemountainsgazette.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bluemountainsgazette.com.au Daily Mail and Mail on Sunday newspapers.